论文部分内容阅读
起搏技术的概况:安装永久性起搏器的指证是伴有晕厥(典型的阿-斯综合征发作)或眩晕的心动过缓,尤其是固定或间歇性完全性房室传导阻滞.指证范围其后扩大到包括动态心电图监测未能证实的可疑心动过缓,现又扩大到包括预防或中止某些快速性心律失常.目前,除了在心脏直视手术或偶然在不能采取静脉途径安装起搏器时外,几乎不再使用心外膜(心肌)导线.经皮导引管的应用使由静脉途径安装起搏器的技术简单化,但也有产生潜在致命性并发症的危险,如
Overview of Pacing Technology: The indications for installing a permanent pacemaker are bradycardia associated with fainting (typical Asperger’s syndrome) or dizziness, especially with fixed or intermittent atrioventricular block. The scope was subsequently expanded to include suspicious suspicious bradycardia that was not demonstrated by Holter monitoring and is now being expanded to include the prevention or discontinuation of some tachyarrhythmia.At present, apart from occasional open-heart surgery or occasional cannibalization The use of epicardial (cardiac) leads is almost no longer used outside of pacemakers, and the use of percutaneous catheters simplifies the technique of installing pacemakers by the venous approach, but also poses the potential for potentially fatal complications such as